Iron nanomedicines induce Toll-like receptor activation, cytokine production and complement activation

Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants

Stephanie C. Eisenbarth, Oscar R. Colegio, William O’Connor et al. · Nature · 2008 · 1.5K citations · Full text

Life Sciences, Biochemistry, Immunology +14

Cutting Edge: Inflammasome Activation by Alum and Alum’s Adjuvant Effect Are Mediated by NLRP3

Hanfen Li, Stephen B. Willingham, Jenny P.‐Y. Ting et al. · The Journal of Immunology · 2008 · 653 citations · Full text

Life Sciences, Immunology, Pathology +17

Intravenous Iron Optimizes the Response to Recombinant Human Erythropoietin in Cancer Patients With Chemotherapy-Related Anemia: A Multicenter, Open-Label, Randomized Trial

Michael Auerbach, Harold S. Ballard, J. Richard Trout et al. · Journal of Clinical Oncology · 2004 · 413 citations

Medicine, Hematology, Pharmacology +15

C3 Shunt Activation in Human Serum Chelated with EGTA

Douglas P. Fine, Samuel R. Marney, Daniel G. Colley et al. · The Journal of Immunology · 1972 · 304 citations

Life Sciences, Biochemistry, Immunology +10

A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer®), a new intravenous iron preparation and its clinical implications

Markus Jahn, Hans B. Andreasen, Sören Fütterer et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2011 · 254 citations

Medicine, Hematology, Nutritional Sciences +14